Several local insurance companies have halted sales of overseas travel insurance policies that cover against medical expenses due to sudden illness, in a bid to curb potential losses amid payouts for COVID-19, company data showed.
As a result, people might find it more difficult to purchase insurance policies with coverage of medical expenses for sudden illness, which is required of travelers by some foreign governments, such as in the EU.
Since many insurers only offer travel insurance that compensates for losses in accidents or covers expenses for emergency rescue, travelers, if infected with COVID-19 abroad, would likely have to pay for their medical treatment.
Photo: CNA
Insurers are halting sales of travel insurance as the amount of compensation for COVID-19 insurance policies had grown to NT$5.47 billion (US$183.92 million) as of Monday last week, nearly twice the premiums of NT$2.79 billion from sales of such products, Financial Supervisory Commission (FSC) data showed.
All insurance companies have terminated sales of COVID-19 insurance policies, with only a few vaccine insurance policies still available, the commission said.
Fubon Insurance Co (富邦產險) yesterday said on its Web site that it had suspended its travel inconvenience insurance policy as it is modifying the terms of the product, but still offers another policy, dubbed “travel safety insurance.”
Unlike the former policy, which covers against medical expenses, the travel safety insurance policy only covers expenses of emergency rescues, as well as losses from theft and fire, corporate data showed.
Cathay Century Insurance Co (國泰世紀產險) last week announced that it would stop selling its travel inconvenience insurance and Schengen travel insurance because of numerous COVID-19 alerts overseas.
The insurance arm of Cathay Financial Holding Co (國泰金控) continues to sell another policy, also called “travel safety insurance,” which compensates those who are hurt in accidents abroad or their families if they die, corporate data showed.
Taiwan Life Insurance Co (台灣人壽) and CTBC Insurance Co (中國信託產險), insurance units of CTBC Financial Holding Co (中信金控), no longer offer travel insurance that covers sudden illness on their Web sites.
Nan Shan Life Insurance Co (南山人壽) has not suspended its travel insurance with coverage for medical expenses due to sudden illness, making it one of the few local insurers that still offers such a policy, corporate data showed.
RUN IT BACK: A succesful first project working with hyperscalers to design chips encouraged MediaTek to start a second project, aiming to hit stride in 2028 MediaTek Inc (聯發科), the world’s biggest smartphone chip supplier, yesterday said it is engaging a second hyperscaler to help design artificial intelligence (AI) accelerators used in data centers following a similar project expected to generate revenue streams soon. The first AI accelerator project is to bring in US$1 billion revenue next year and several billion US dollars more in 2027, MediaTek chief executive officer Rick Tsai (蔡力行) told a virtual investor conference yesterday. The second AI accelerator project is expected to contribute to revenue beginning in 2028, Tsai said. MediaTek yesterday raised its revenue forecast for the global AI accelerator used
Taiwan Semiconductor Manufacturing Co (TSMC, 台積電) has secured three construction permits for its plan to build a state-of-the-art A14 wafer fab in Taichung, and is likely to start construction soon, the Central Taiwan Science Park Bureau said yesterday. Speaking with CNA, Wang Chun-chieh (王俊傑), deputy director general of the science park bureau, said the world’s largest contract chipmaker has received three construction permits — one to build a fab to roll out sophisticated chips, another to build a central utility plant to provide water and electricity for the facility and the other to build three office buildings. With the three permits, TSMC
TEMPORARY TRUCE: China has made concessions to ease rare earth trade controls, among others, while Washington holds fire on a 100% tariff on all Chinese goods China is effectively suspending implementation of additional export controls on rare earth metals and terminating investigations targeting US companies in the semiconductor supply chain, the White House announced. The White House on Saturday issued a fact sheet outlining some details of the trade pact agreed to earlier in the week by US President Donald Trump and Chinese President Xi Jinping (習近平) that aimed to ease tensions between the world’s two largest economies. Under the deal, China is to issue general licenses valid for exports of rare earths, gallium, germanium, antimony and graphite “for the benefit of US end users and their suppliers
Dutch chipmaker Nexperia BV’s China unit yesterday said that it had established sufficient inventories of finished goods and works-in-progress, and that its supply chain remained secure and stable after its parent halted wafer supplies. The Dutch company suspended supplies of wafers to its Chinese assembly plant a week ago, calling it “a direct consequence of the local management’s recent failure to comply with the agreed contractual payment terms,” Reuters reported on Friday last week. Its China unit called Nexperia’s suspension “unilateral” and “extremely irresponsible,” adding that the Dutch parent’s claim about contractual payment was “misleading and highly deceptive,” according to a statement
RSS